Copyright
©The Author(s) 2023.
World J Gastroenterol. Aug 28, 2023; 29(32): 4873-4882
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4873
Published online Aug 28, 2023. doi: 10.3748/wjg.v29.i32.4873
Table 4 Decompensation risk stratification based on albumin-bilirubin grade at baseline
| ALBI grade | Decompensation at 3-yr (n, %) | P value | OR (95%CI) | P value |
| 1 | 2/64 (3.1) | - | 1.0 (reference) | - |
| 2 | 12/53 (22.6) | 0.003 | 7.83 (1.75-35.01) | 0.007 |
| 3 | 3/6 (50) | < 0.001 | 23.33 (3.88-140.12) | 0.001 |
- Citation: Navadurong H, Thanapirom K, Wejnaruemarn S, Prasoppokakorn T, Chaiteerakij R, Komolmit P, Treeprasertsuk S. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. World J Gastroenterol 2023; 29(32): 4873-4882
- URL: https://www.wjgnet.com/1007-9327/full/v29/i32/4873.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i32.4873